CARSGEN Trademark

Trademark Overview


On Tuesday, April 9, 2024, a trademark application was filed for CARSGEN with the United States Patent and Trademark Office. The USPTO has given the CARSGEN trademark a serial number of 79402612. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, April 2, 2025. This trademark is owned by CARsgen Therapeutics Co., Ltd. The CARSGEN trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases ; drugs for medical purposes, namely, pharmaceutical preparations for treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biological preparations for medical purposes for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; medicinal solutions for injection, namely, medicines for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, ...

Medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; human tissue bank services; alternative medicine services; therapy services, namely, medical therapy, medicine therapy, immunotherapy, cell therapy, gene therapy, antibody therapy, antibody-drug conjugate therapy, radiation therapy, chemotherapy, or stem cell therapy; telemedicine services; health care; medical clinic services

Scientific research; scientific laboratory services; research and development of new products for others; technical project studies, namely, conducting scientific feasibility studies; technological research in the field of pharmaceutical studies, biotechnology, medicine, immunotherapy; chemical research; chemistry services, namely, chemist services and chemistry consultation; chemical analysis; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research
carsgen

General Information


Serial Number79402612
Word MarkCARSGEN
Filing DateTuesday, April 9, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, April 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases ; drugs for medical purposes, namely, pharmaceutical preparations for treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biological preparations for medical purposes for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; medicinal solutions for injection, namely, medicines for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biomedicine for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; blood for medical purposes; pre-filled syringes for medical purposes filled with pharmaceutical preparations for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biological tissue cultures for medical purposes; serotherapeutic medicines for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases
Goods and ServicesMedical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; human tissue bank services; alternative medicine services; therapy services, namely, medical therapy, medicine therapy, immunotherapy, cell therapy, gene therapy, antibody therapy, antibody-drug conjugate therapy, radiation therapy, chemotherapy, or stem cell therapy; telemedicine services; health care; medical clinic services
Goods and ServicesScientific research; scientific laboratory services; research and development of new products for others; technical project studies, namely, conducting scientific feasibility studies; technological research in the field of pharmaceutical studies, biotechnology, medicine, immunotherapy; chemical research; chemistry services, namely, chemist services and chemistry consultation; chemical analysis; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 22, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 22, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCARsgen Therapeutics Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, August 22, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 23, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, October 22, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 23, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 29, 2024REFUSAL PROCESSED BY MPU
Tuesday, October 22, 2024ASSIGNED TO EXAMINER
Tuesday, April 1, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 1, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 1, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, April 1, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 1, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 1, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, November 17, 2024REFUSAL PROCESSED BY IB